General Information of Drug (ID: DMDVNVI)

Drug Name
AZD2995
Indication
Disease Entry ICD 11 Status REF
Alzheimer disease 8A20 Phase 1 [1]
Cross-matching ID
TTD ID
D06JPY

References

1 ClinicalTrials.gov (NCT00692705) Positron Emission Tomography (PET) Study With [11C]AZD2995 and [11C]AZD2184, Candidate PET Ligands for Amyloid. U.S. National Institutes of Health.